MSC-AS1 knockdown inhibits cell growth and temozolomide resistance by regulating miR-373-3p/CPEB4 axis in glioma through PI3K/Akt pathway

lncRNA MSC‐AS1 activates Wnt/β‐catenin signaling pathway to modulate cell proliferation and migration in kidney renal clear cell carcinoma via miR‐3924/WNT5A

(2020) Zhaoxiong Hu et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

LncRNA MSC-AS1 aggravates nasopharyngeal carcinoma progression by targeting miR-524-5p/nuclear receptor subfamily 4 group A member 2 (NR4A2)

(2020) Hongchao Yao et al.   Cancer Cell International

The RNA-binding protein Cpeb4 is a novel positive regulator of osteoclast differentiation

(2020) Yasuhiro Arasaki et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Long noncoding RNA MSC‐AS1 promotes hepatocellular carcinoma oncogenesis via inducing the expression of phosphoglycerate kinase 1

(2020) Cong Cao et al.   Cancer Medicine

Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma

(2019) Jing-Xian Gu et al.   WORLD JOURNAL OF GASTROENTEROLOGY

The role of lncRNA MSC-AS1/miR-29b-3p axis-mediated CDK14 modulation in pancreatic cancer proliferation and Gemcitabine-induced apoptosis

(2019) Yunpeng Sun et al.   CANCER BIOLOGY & THERAPY

lncRNA SNHG16 promotes glioma tumorigenicity through miR-373/EGFR axis by activating PI3K/AKT pathway

(2019) Xiang-Yang Zhou et al.   GENOMICS

PI3K/Akt/mTOR inhibitors in cancer: At the bench and bedside

(2019) Ali S. Alzahrani   SEMINARS IN CANCER BIOLOGY

LncRNA MSC-AS1 promotes osteogenic differentiation and alleviates osteoporosis through sponging microRNA-140–5p to upregulate BMP2

(2019) Naidong Zhang et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Silencing lncRNA FOXD2-AS1 inhibits proliferation, migration, invasion and drug resistance of drug-resistant glioma cells and promotes their apoptosis via microRNA-98-5p/CPEB4 axis

(2019) Naibing Gu et al.   Aging-US

Mechanism of long noncoding RNAs as transcriptional regulators in cancer

(2019) Yan Huang et al.   RNA Biology

MiR-373-3p enhances the chemosensitivity of gemcitabine through cell cycle pathway by targeting CCND2 in pancreatic carcinoma cells

(2018) Wenjie Hu et al.   BIOMEDICINE & PHARMACOTHERAPY

MiR-634 sensitizes glioma cells to temozolomide by targeting CYR61 through Raf-ERK signaling pathway

(2018) Zhigang Tan et al.   Cancer Medicine

CPEB4 promotes growth and metastasis of gastric cancer cells via ZEB1-mediated epithelial–mesenchymal transition

(2018) Gan Cao et al.   OncoTargets and Therapy

Therapeutic Potential of Targeting PI3K/AKT Pathway in Treatment of Colorectal Cancer: Rational and Progress

(2017) Afsane Bahrami et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

LncRNA CASC2 Interacts With miR-181a to Modulate Glioma Growth and Resistance to TMZ Through PTEN Pathway

(2017) Yiwei Liao et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

miR-373-3p Targets DKK1 to Promote EMT-Induced Metastasis via the Wnt/β-Catenin Pathway in Tongue Squamous Cell Carcinoma

(2017) Junquan Weng et al.   Biomed Research International

Mcl-1 inhibitors: a patent review

(2016) Lijia Chen et al.   EXPERT OPINION ON THERAPEUTIC PATENTS

The PI3K AKT pathway in the pathogenesis of prostate cancer

(2016) Xiaofei Wen   Frontiers in Bioscience-Landmark

TAZ promotes temozolomide resistance by upregulating MCL-1 in human glioma cells

(2015) Tian Tian et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Krüppel-like factor 9 inhibits glioma cell proliferation and tumorigenicity via downregulation of miR-21

(2015) Shuyun Huang et al.   CANCER LETTERS

Small-Molecule and Peptide Inhibitors of the Pro-Survival Protein Mcl-1

(2015) Andrew M. Beekman et al.   ChemMedChem

Expression of CPEB4 in Human Glioma and Its Correlations With Prognosis

(2015) Wanming Hu et al.   MEDICINE

Expression of CPEB4 in invasive ductal breast carcinoma and its prognostic significance

(2015) Tian Han et al.   OncoTargets and Therapy

VAMP8 facilitates cellular proliferation and temozolomide resistance in human glioma cells

(2014) Yuanyuan Chen et al.   NEURO-ONCOLOGY

CPEB4 is a candidate biomarker for defining metastatic cancers and directing personalized therapies

(2013) Huiyu Xu et al.   MEDICAL HYPOTHESES

Targeting Mcl-1 for the therapy of cancer

(2011) Bridget A Quinn et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

miRNAs in human cancer

(2010) Thalia A Farazi et al.   JOURNAL OF PATHOLOGY

A survey of the anti-apoptotic Bcl-2 subfamily expression in cancer types provides a platform to predict the efficacy of Bcl-2 antagonists in cancer therapy

(2010) W J Placzek et al.   Cell Death & Disease

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

(2009) Roger Stupp et al.   LANCET ONCOLOGY